Navigation Links
ULURU Inc. Announces the Filing of a 510(k) Application for Altrazeal® Collagen
Date:5/4/2011

ADDISON, Texas, May 4, 2011 /PRNewswire/ -- ULURU Inc. (NYSE AMEX: ULU) announced today that it has filed a 510(k) application with the U.S. Food and Drug Administration to obtain marketing authorization for Altrazeal® Collagen.

Collagen containing wound care products represent a growing segment of the advanced wound care market. Collagen stimulates cellular migration and contributes to new tissue development. Collagen dressings encourage the deposition and organization of newly formed collagen, creating an environment that fosters healing. Biomaterials with collagen stimulate the wound healing cascade, recruiting specific cells during this process and ultimately, enhance wound healing.

Commenting on the Company's 510(k) application, Kerry P. Gray, President and CEO of ULURU Inc., stated, "Altrazeal® Collagen is an important line extension for our wound care franchise. Initial studies indicate that combining Altrazeal® with collagen provides accelerated wound healing compared to collagen alone, potentially providing additional synergistic benefits. The collagen market segment is a growing and important category within advanced wound care. Having Altrazeal® Collagen available will enable our sales representatives to provide an additional alternative therapy to the wound care professional to treat chronic wounds."

Mr. Gray continued, "The expansion of the Altrazeal® product line to include a collagen product and a silver containing product is an important component of our wound care strategy. Having this full compliment of products will enable us to more effectively compete in the major wound care market segments. Altrazeal® Collagen further enhances the value of the Company's Altrazeal® franchise and makes this asset more attractive to potential strategic partners."

About ULURU Inc.:

ULURU Inc. is a specialty pharmaceutical company focused on the development of a por
'/>"/>

SOURCE ULURU Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. ULURU Inc. Announces the Commencement of First Clinical Study Using Altrazeal(TM) Silver
2. ULURU Inc. to Present Altrazeal(TM) Clinical Evidence and Advanced Therapeutic Research at the Diabetic Foot Global Conference (DFCon) 2009
3. ULURU Inc. Announces Conference Call to Discuss Financial Results for the Third Quarter Ended September 30, 2009 and to Provide a Business Update
4. ULURU Inc. Invited to Present Altrazeal(TM) Research at 10th Annual Wound Healing Science and Industry Conference
5. ULURU Inc. Obtains Status of Approved Supplier With McKesson.
6. ULURU Inc. Reports Second Quarter 2010 Financial Results
7. ULURU Inc. Announces Conference Call
8. ULURU Inc. Provides Altrazeal® Clinical Update
9. ULURU Inc. Reports Third Quarter 2010 Financial Results
10. ULURU Inc. to Raise $500,000 in Registered Direct Offering
11. ULURU Inc. Announces Agreement With Exciton to Develop Antimicrobial Dressing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/6/2015)... , 6. März 2015  Unfors ... Röntgenstrahlen, feierte auf dem European Congress of ... , Österreich, die 1.000. Installation seines Systems ... Logo - http://photos.prnewswire.com/prnh/20150304/179432LOGO ... der in Echtzeit Informationen über die Dosis ...
(Date:3/6/2015)... 6, 2015  AbbVie (NYSE: ABBV ) ... on Thursday, March 12, 2015. Richard A. Gonzalez ... a question and answer session at 8:30 a.m. Central ... presentation will be accessible through AbbVie,s Investor Relations Web ... the session will be available later that day. ...
(Date:3/6/2015)... , March 6, 2015   Veracyte, Inc. ... demonstrating that diagnostic tests that use increasing numbers of ... reduce the specificity of test results, leading to an ... erroneously diagnosed as cancerous. In addition, these new data ... the malignancies leading to "false negatives." The data were ...
Breaking Medicine Technology:Unfors RaySafe, ein Unternehmen von Fluke Biomedical, feiert 1.000. Installation seines Systems zur Echtzeit-Strahlendosimetrie 2Unfors RaySafe, ein Unternehmen von Fluke Biomedical, feiert 1.000. Installation seines Systems zur Echtzeit-Strahlendosimetrie 3Veracyte Announces New Data that Inform Optimal Use of Molecular Testing in Preoperative Thyroid Nodule Assessment 2Veracyte Announces New Data that Inform Optimal Use of Molecular Testing in Preoperative Thyroid Nodule Assessment 3Veracyte Announces New Data that Inform Optimal Use of Molecular Testing in Preoperative Thyroid Nodule Assessment 4Veracyte Announces New Data that Inform Optimal Use of Molecular Testing in Preoperative Thyroid Nodule Assessment 5Veracyte Announces New Data that Inform Optimal Use of Molecular Testing in Preoperative Thyroid Nodule Assessment 6
... Inc. (NYSE AMEX: ULU) today announced that it ... ended September 30, 2011 financial results and to provide a ... a.m. Eastern Time. To participate in the conference ... 429-1388 (access code 23823#) five to ten minutes prior to ...
... FRANCISCO, Nov. 11, 2011 Boston Scientific Corporation ... the EVOLVE First Human Use trial demonstrating the ... to the PROMUS Element™ Everolimus-Eluting Stent System in ...  The trial provided 30-day clinical and six-month angiographic ...
Cached Medicine Technology:ULURU Inc. Announces Conference Call to Discuss Financial Results for the Third Quarter Ended September 30, 2011 and to Provide a Business Update 2Boston Scientific SYNERGY™ Stent Demonstrates Comparable Safety and Effectiveness Outcomes Versus PROMUS Element™ Platinum Chromium Stent 2Boston Scientific SYNERGY™ Stent Demonstrates Comparable Safety and Effectiveness Outcomes Versus PROMUS Element™ Platinum Chromium Stent 3Boston Scientific SYNERGY™ Stent Demonstrates Comparable Safety and Effectiveness Outcomes Versus PROMUS Element™ Platinum Chromium Stent 4Boston Scientific SYNERGY™ Stent Demonstrates Comparable Safety and Effectiveness Outcomes Versus PROMUS Element™ Platinum Chromium Stent 5
(Date:3/6/2015)... March 06, 2015 Further solidifying their ... Medical Doctor Associates announced today that the company has ... winning the Best of Staffing Talent Award five years ... Best of Staffing Talent Diamond winners are proven industry ... to them by the individuals they have helped find ...
(Date:3/6/2015)... 2015 Johnson & Johnson and Ethicon ... March 5, 2015 in Superior Court in the State ... a jury of 12 awarded Mrs. Perry $700,000 in ... with an Ethicon TVT Abbrevo plastic sling for stress ... women also awarded $5 million in punitive damages. , ...
(Date:3/6/2015)... Covington, La (PRWEB) March 06, 2015 ... reduced function despite medical therapy. If you (or someone ... due to knee osteoarthritis, you may be interested in ... with Covington Orthopedic announced today that he is one ... from Cytori Therapeutics to begin enrolling subjects as part ...
(Date:3/6/2015)... March 06, 2015 Truly Nolen, the ... to announce the grand opening of their first independently-owned ... area down to the Fort Mill – Rock Hill, ... February 27th, 2015 at their new location. ... years of collective experience in the pest control industry. ...
(Date:3/6/2015)... (PRWEB) March 06, 2015 Yisrayl Hawkins, ... Abilene, Texas, has released a new publication explaining how ... , The article titled “Microorganisms Do Much ... explaining how tiny microorganisms were created and designed to ... aware of some of the functions of these micro-kingdom, ...
Breaking Medicine News(10 mins):Health News:Cross Country Healthcare: Medical Doctor Associates Earns Inavero's 2015 Best of Staffing Talent Diamond Award 2Health News:Cross Country Healthcare: Medical Doctor Associates Earns Inavero's 2015 Best of Staffing Talent Diamond Award 3Health News:Johnson & Johnson Hit with $5.7 Million Verdict in Pelvic Mesh Trial Announces Matthews & Associates Law Firm 2Health News:Johnson & Johnson Hit with $5.7 Million Verdict in Pelvic Mesh Trial Announces Matthews & Associates Law Firm 3Health News:Kevin Darr, M.D. is Now Enrolling Patients in a New FDA-Approved Clinical Trial Evaluating Adipose-Derived Regenerative Cells in the Treatment of Knee Osteoarthritis 2Health News:First Truly Nolen Franchise Opening in North Carolina 2Health News:Yisrayl Hawkins Tells Scientists Exactly What Makes Life Function Properly in New Publication 2
... , , , ... California Cardiothoracic Surgery Center specializes in cardiothoracic surgery ... not seem like serious symptoms. In fact, most people brush off ... simple symptoms can be indications of the need for ...
... , , , , ... affects 40 percent of the world,s population, often resulting in patches of ... KP is most prevalent in the teenage years but may continue throughout ... , Dr. Alan B. Fleischer, professor and chair of the ...
... role, study says , MONDAY, July 27 (HealthDay News) -- ... blood pressure, may experience a "silent stroke" and won,t even ... truly silent, because they have been linked to memory and ... of dementia," study author Dr. Perminder Sachdev, a neuropsychiatry professor ...
... , , , ... holidays, and job searching, along with many other activities and errands, it ... simplest option, and at a few dollars a day, it may not ... eating out every month, hitting tight budgets. According to Fast Food Nation, ...
... (PHILADELPHIA) Smoking has once again been implicated in ... way of cigarette smoking may increase the likelihood that ... from the Kimmel Cancer Center at Jefferson. Their study ... Surgery . The culprit behind the increased ...
... , , MINNEAPOLIS and ... Health recently designated Children,s Hospitals and Clinics of Minnesota,s two ... Minnesota has the sixth busiest pediatric emergency department in the ... around 450 trauma cases each year. Children,s voluntarily participated ...
Cached Medicine News:Health News:Southern California Surgical Center (heart411.com) Specializes in Mitral Valve Replacement 2Health News:What Is Keratosis Pilaris (KP)? 2Health News:People Over 60 at Risk for 'Silent Stroke' 2Health News:As Good As a Deli, For the Price of Making It At Home 2Health News:Smoking increases potential for metastatic pancreatic cancer 2Health News:Children's Hospitals and Clinics of Minnesota Receive Level III Trauma Designation 2Health News:Children's Hospitals and Clinics of Minnesota Receive Level III Trauma Designation 3
... 6-inch Electro-Dermatome. This is the only ... six inch graft can cover most adult ... seams. This dermatome has been designed to ... is decreased considerably and the handle temperature ...
A finely parallel striated (scratched) clear plastic membrane encapsulated between glass plates....
BD Visitec IOL Manipulator (Fenzl), blunt tip angled 45, 12.0 mm from end, fits 0.20 mm diameter holes and larger (3/bx, 1 bx/ca). For positioning intraocular lenses. Sure grip handles hand ridge ind...
Hunkeler lens manipulator, angled. Also available in titanium....
Medicine Products: